NEXT Bioinformatics: Activity Report: 2015 - 2018

Deltagere fra Aalborg Universitetshospital, Dennis Weerdt, Jonas Have(Aalborg University Hospital), Lasse Hjort Jakobsen(Aalborg University Hospital), Charles Vesteghem(Aalborg University Hospital), Anna A. Schönherz(Aalborg University Hospital), Mads Sønderkær(Aalborg University), Kasper Lindblad Nielsen(Aalborg University Hospital), Hans Erik Johnsen(Herlev Hospital), Julie Støve Bødker(Chr. Hansen (Denmark)), Martin Bøgsted(Chr. Hansen (Denmark)), Anders Ellern Bilgrau(Chr. Hansen (Denmark)), Rasmus Froberg Brøndum(Aarhus University), Anders Sune Pedersen, Karen Dybkær(Aalborg University Hospital)

Unknown

February 1, 2019

Cited by 0

Related Papers

MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

|Blood|2013|683

Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with R-CHOP: report from an International DLBCL Rituximab-CHOP Consortium Program Study

|Blood|2012|396

Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma

|Blood|2009|390

Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study

|Leukemia|2012|362

Construction of Reference Chromosome-Scale Pseudomolecules for Potato: Integrating the Potato Genome with Genetic and Physical Maps

|G3 Genes Genomes Genetics|2013|286